Advances In Biotechnology Research Articles

Site-directed mutagenesis and molecular docking simulations identified the crucial substrate binding site asparagine 101 of xyloglucan endotransglycosylase/hydrolase (XTH) in woody plants

Xyloglucan endotransglycosylase/hydrolase (XTH) is a key enzyme in plant cell wall remodeling. Previous investigations on the angiosperm Populus tomentosa identified 11 PtoXTH proteins with the XTH catalytic motif. Surprisingly, only two (PtoXTH27 and PtoXTH34) exhibited xyloglucan endotransglucosylase (XET) activity, suggesting the presence of additional key substrate binding or catalytic activity sites within XTH proteins. To test this hypothesis, we performed site-directed mutagenesis on selected amino acids in PtoXTH27 and PtoXTH34 and characterized their biochemical properties. Molecular docking simulations and biochemical analyses revealed that N101 is a critical substrate binding site, while Q80, M81, and V180 are essential functional residues influencing XET activity in XTH proteins. Notably, XET-deficient PtoXTH26 regained activity following site-directed mutation, underscoring the significance of these residues. Expanding our study to the gymnosperm Larix kaempferi, we identified two XTH proteins: LkXTH1, which exhibited both the key substrate binding site and XET activity, and LkXTH2, which lacked XET activity. Intriguingly, LkXTH2 regained XET activity after site-directed mutation, highlighting the versatility of the newly identified substrate binding site across different woody plants subphyla. This research provides a theoretical basis for the rapid identification of enzymatically active members within the XTH gene family in woody plants. Furthermore, our findings offer insights into the targeted engineering of XTH enzymes, paving the way for advancements in plant biotechnology and crop improvement.

Contactless Single Cell Extraction from Monolayer Cell Culture Using A MEMS Acoustic Droplet Ejector.

To achieve a contactless and damage-less extraction of a single (or a few) human retinal pigment epithelial (RPE) cell(s) from a cell monolayer with acoustic droplet ejection. An acoustic droplet ejector based on a self-focusing acoustic transducer (SFAT) is designed, microfabricated, and placed on a precision movable stage that aligns it to the targeted cell(s) in a Petri dish. The device delivers 20.1 MHz focused ultrasound (FUS) with a focal diameter of 100 μm, which ejects droplets capable of extracting and transferring only the targeted cell(s) from a monolayer. The extraction and collection of 1-10 cells are successfully demonstrated. The number of ejected cells can be controlled by the FUS pulse width. As confirmed by fluorescence-based cell viability assays and re-culture experiments, the ejected cell(s) and remaining monolayer cells are intact without damage after cell ejection. Furthermore, real-time reverse transcription polymerase chain reaction (RT-PCR) tests for both housekeeping genes (GAPDH and β -actin) and RPE-specific genes (MITF, PEDF, and PMEL17) show no significant difference between the acoustically ejected cells and those collected manually with a micropipette. The proposed technology realizes a contactless, damage-free extraction of cells with high spatial resolution and precise control of the number of cells ejected, with a simple setup. This powerful technology not only enables efficient, high-precision cell extraction for quality check applications but also opens new avenues for other advanced biotechnologies such as bioprinting.

Bridging tradition with innovation: Revolutionzing sericulture through biotechnological advancements

Sericulture, the practice of rearing silkworms (Bombyxmori L.) for silk production, has been an integral part of global textile industries for millennia. With the advent of biotechnology, particularly advancements in molecular biology and genetics, new avenues have opened up to enhance various aspects of sericulture. This abstract clearly indicates the multifaceted applications of biotechnology in sericulture, focusing on genetic improvement of silkworms, disease management strategies, enhancement of silk production efficiency and promotion of environmental sustainability. Sericulture encompasses the entire process of silk production, from silkworm rearing to silk reeling and textile manufacturing. Historically significant and economically vital in many regions, sericulture faces contemporary challenges such as disease outbreaks, genetic limitations and environmental pressures. Biotechnology offers promising solutions by leveraging tools and techniques from molecular biology, genetics and bioprocess engineering to address these challenges and enhance the productivity, quality and sustainability of silk production.

Bacterial Membrane Vesicles as a Novel Vaccine Platform against SARS-CoV-2.

Throughout history, infectious diseases have plagued humanity, with outbreaks occurring regularly worldwide. Not every outbreak affects people globally; however, in the case of Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), it reached a pandemic level within a remarkably short period. Fortunately, advancements in medicine and biotechnology have facilitated swift responses to the disease, resulting in the development of therapeutics and vaccines. Nevertheless, the persistent spread of the virus and the emergence of new variants underscore the necessity for protective interventions, leading researchers to seek more effective vaccines. Despite the presence of various types of vaccines, including mRNA and inactivated vaccines against SARS-CoV-2, new platforms have been investigated since the pandemic, and research on bacterial membrane vesicles (BMVs) has demonstrated their potential as a novel COVID-19 vaccine platform. Researchers have explored different strategies for BMV-based COVID-19 vaccines, such as mixing the vesicles with antigenic components of the virus due to their adjuvant capacity or decorating the vesicles with the viral antigens to create adjuvanted delivery systems. These approaches have presented promising results in inducing robust immune responses, but obstacles such as reproducibility in obtaining and homogeneous characterization of BMVs remain in developing vesicle-based vaccines. Overall, the development of BMV-based vaccines represents a novel and promising strategy in the fight against COVID-19. Additional research and clinical trials are needed to further evaluate the potential of these vaccines to offer long-lasting protection against SARS-CoV-2 and its evolving variants.

Economical Sugar Beet Production: Biotechnological Advances to Improve Yield in Conditions of Abiotic and Biotic Stress

Economical Sugar Beet Production: Biotechnological Advances to Improve Yield in Conditions of Abiotic and Biotic Stress

Advances in Microbial Biotechnology for Sustainable Alternatives to Petroleum-Based Plastics: A Comprehensive Review of Polyhydroxyalkanoate Production.

The industrial production of polyhydroxyalkanoates (PHAs) faces several limitations that hinder their competitiveness against traditional plastics, mainly due to high production costs and complex recovery processes. Innovations in microbial biotechnology offer promising solutions to overcome these challenges. The modification of the biosynthetic pathways is one of the main tactics; allowing for direct carbon flux toward PHA formation, increasing polymer accumulation and improving polymer properties. Additionally, techniques have been implemented to expand the range of renewable substrates used in PHA production. These feedstocks are inexpensive and plentiful but require costly and energy-intensive pretreatment. By removing the need for pretreatment and enabling the direct use of these raw materials, microbial biotechnology aims to reduce production costs. Furthermore, improving downstream processes to facilitate the separation of biomass from culture broth and the recovery of PHAs is critical. Genetic modifications that alter cell morphology and allow PHA secretion directly into the culture medium simplify the extraction and purification process, significantly reducing operating costs. These advances in microbial biotechnology not only enhance the efficient and sustainable production of PHAs, but also position these biopolymers as a viable and competitive alternative to petroleum-based plastics, contributing to a circular economy and reducing the dependence on fossil resources.

A Review on the Impact of Climate Change on Plant Pathogen Interactions

Climate change significantly affects plant-pathogen interactions, creating major challenges for global agriculture and food security. It alters pathogen distribution, biology, and life cycles, while also impacting plant physiology and defense mechanisms. Predictive models are crucial for forecasting pathogen spread under various climate scenarios, but they face limitations due to uncertainties and the complexity of biological interactions. Advances in biotechnology and genomics, including marker-assisted selection, gene editing, and the study of plant-microbe interactions, offer promising solutions for developing climate-resilient crops. Implementing sustainable agricultural practices, such as conservation agriculture, agroforestry, and efficient water management, is vital for enhancing resilience. Integrated Pest Management (IPM) strategies, which combine biological, cultural, and chemical methods, are essential for adaptive pest control. To support these efforts, policies and regulatory frameworks, incentive programs, and international cooperation are necessary to promote the widespread adoption of these practices. There are significant research gaps, especially in long-term monitoring and interdisciplinary studies, that are crucial for a comprehensive understanding of climate change's effects on agriculture. Addressing these challenges requires global collaborative research initiatives that facilitate the exchange of knowledge, resources, and technologies, advancing our understanding and mitigation of climate impacts on agriculture.

Solid-State Electrodes Towards a Real-Time Sensor Array for Health Monitoring

The healthcare industry has been transformed by advances in biotechnology, resulting in improved health outcomes. Central to this has been advances in medical diagnostics that can both monitor patients as well as provide actionable data at the point-of-care. However, further improvements are needed to maximize the utility of diagnostics at times where acute care may be required, such as when individuals are unstable after experiencing physical trauma. When medical resources are limited, the ability to rapidly and effectively triage patients that have experienced trauma is critical to maximizing health outcomes. Notably, individuals that have experienced significant trauma can degrade quickly. Therefore, continuous monitoring approaches are needed that can provide critical biometric and biomarker information that will enable updating of the triage in real-time.At present time, patients are assessed continuously using biometric monitoring. However, biometrics are often a lagging indicator to biochemical markers, and thus while easier to measure, less informative. Currently, the ISTAT-8 is a point-of-care unit to perform an automated, rapid biochemical panel that can assess the patient’s ability to maintain homeostasis by monitoring eight biomarkers. However, the ISTAT-8 captures biochemical data only at a point in time instead of continuously; this is a drawback, as the health of patients who have undergone trauma can improve or deteriorate rapidly. Therefore, a continuous biochemical monitoring solution is needed to allow for triage to happen in real-time.Advances in biotechnology have for the first time made real-time biochemical sensing a reality. Unfortunately, commercial continuous biochemical sensors to-date are limited to subcutaneous continuous glucose monitors (CGMs). CGMs monitor glucose concentrations in the interstitial fluid (ISF), which strongly correlates to blood values. While the CGM is now commonly used, the current devices are not easily multiplexed. Therefore, a scalable, easy to insert system is needed to perform multiplexed measurements; microneedle-based platforms have the promise to enable sensing in the ISF leveraging five or more distinct sensors.Here we present a solid-state platform that can enable multiplexed sensing leveraging hollow, wicking microneedles in fluidic contact with solid-state electrodes. Our approach leverages optimized sensor formulations and electrode materials fabricated onto a printed circuit board (PCB). The putative sensor array can be produced in a modular fashion leveraging scalable technologies and processes. Notably, this talk focuses on methods and approaches to fabricate an array of solid-state sensors that are capable of detecting ions and metabolites over extended periods (> 1 week) and can be readily integrated with microneedles for sensing interstitial fluid.

Graphene in Medicine: Revolutionizing Healthcare through Advanced Nanomaterials

Nanomaterials, particularly carbon-based structures like graphene nanostructures, have revolutionized science and technology, offering groundbreaking advancements in bioengineering and medicine. These developments have enhanced our ability to detect, diagnose, and treat diseases, leading to significant innovations in therapy methods. The evolving field of graphene synthesis, with its less complex and more effective strategies, has captured the scientific community's interest. This review seeks to delve into the latest progress in the creation and application of graphene-based nanomaterials, especially their role in biomedical applications, with a primary focus on drug delivery systems. Graphene has emerged as a versatile material in the medical field. Its application as a sensor in monitoring vital parameters such as blood pressure and blood sugar levels, as well as nitric oxide levels in oxygen, has been noteworthy. In dentistry, graphene, combined with specific peptides, can identify individual bacterial strains, aiding in accurate disease diagnosis. Its role as an immunosensor is also significant, enabling the detection of trace amounts of substances like growth hormones. In the battle against cancer, graphene has shown promising results. It is actively being researched for broader medical applications including cancer therapy, diagnostic tools for diseases, tissue engineering, implants, DNA sequencing, biomarker identification, genetic material transfer, and in the combined fields of biomedical imaging and neuroscience. This review underscores the potential of graphene in medical science. As research continues, it is anticipated that graphene-based technologies will significantly contribute to personalized therapies, enhancing healthcare quality. The conclusion of this review emphasizes the need for ongoing research to explore and refine graphene-derived smart therapeutics. Such advancements will not only improve patient care but also drive us towards the zenith of human welfare, showcasing the transformative impact of nanotechnology in healthcare.Keywords: Graphene, Biomedical Applications, Drug Delivery Systems, Diagnostic Innovations and Personalized Therapeutics

Plant-Derived Extracellular Vesicles as a Novel Frontier in Cancer Therapeutics.

Recent advancements in nanomedicine and biotechnology have unveiled the remarkable potential of plant-derived extracellular vesicles (PDEVs) as a novel and promising approach for cancer treatment. These naturally occurring nanoscale particles exhibit exceptional biocompatibility, targeted delivery capabilities, and the capacity to load therapeutic agents, positioning them at the forefront of innovative cancer therapy strategies. PDEVs are distinguished by their unique properties that facilitate tumor targeting and penetration, thereby enhancing the efficacy of drug delivery systems. Their intrinsic biological composition allows for the evasion of the immune response, enabling the efficient transport of loaded therapeutic molecules directly to tumor sites. Moreover, PDEVs possess inherent anti-cancer properties, including the ability to induce cell cycle arrest and promote apoptotic pathways within tumor cells. These vesicles have also demonstrated antimetastatic effects, inhibiting the spread and growth of cancer cells. The multifunctional nature of PDEVs allows for the simultaneous delivery of multiple therapeutic agents, further enhancing their therapeutic potential. Engineering and modification techniques, such as encapsulation, and the loading of therapeutic agents via electroporation, sonication, and incubation, have enabled the customization of PDEVs to improve their targeting efficiency and therapeutic load capacity. This includes surface modifications to increase affinity for specific tumor markers and the encapsulation of various types of therapeutic agents, such as small molecule drugs, nucleic acids, and proteins. Their plant-derived origin offers an abundant and renewable source to produce therapeutic vesicles, reducing costs and facilitating scalability for clinical applications. This review provides an in-depth analysis of the latest research on PDEVs as emerging anti-cancer agents in cancer therapy.

Lignin lite: Boosting plant power through selective downregulation.

SUMMARY STATEMENTThis article explores the dual benefits of reducing lignin content in plants, which streamlines biofuel production while maintaining robust defence mechanisms. It discusses how plants compensate for lower lignin levels through alternative defence strategies, recent biotechnological advances in lignin modification, and the implications for agriculture and industry.

A review on development of enzymatic biosensors for industrial applications

Enzymatic biosensors are vital tools across various industries due to their high specificity, sensitivity, and rapid response times. They are extensively used in medical diagnostics for monitoring biomarkers like glucose and lactate, environmental monitoring to detect pollutants, food safety and quality assurance, bioprocess control in industrial fermentation, pharmaceutical drug development and quality control, soil health and agrochemical detection in agriculture, and for identifying biological warfare agents. However, several challenges limit their broader adoption and effectiveness in industrial settings. Key challenges include enzyme stability, as enzymes can denature under extreme environmental conditions, reducing sensor lifespan and performance. Variability in enzyme activity and immobilization techniques also leads to inconsistencies, affecting sensor reproducibility and reliability. Complex sample matrices, such as those in environmental and food samples, introduce interference that can affect sensor accuracy. Integrating biosensors into existing industrial processes is another significant challenge, requiring compatibility with automated systems and real-time data processing capabilities. Additionally, high production costs and scalability issues hinder widespread adoption. Regulatory and standardization barriers further complicate the development and deployment of enzymatic biosensors. Despite these limitations, advancements in materials science, nanotechnology, and bioengineering are paving the way for more robust and reliable biosensors. Innovations such as nanomaterial-based enzyme immobilization, synthetic biology for enzyme engineering, and advanced data analytics integration hold promise for overcoming current limitations. Collaborative efforts among researchers, industry stakeholders, and regulatory bodies are essential to accelerate the development and application of enzymatic biosensors in industrial settings. While enzymatic biosensors offer significant potential, addressing these challenges through ongoing research and technological advancements is crucial for their widespread implementation and optimization.

Exploring the Multifaceted Therapeutic Potential of Probiotics: A Review of Current Insights and Applications.

The interplay between human health and the microbiome has gained extensive attention, with probiotics emerging as pivotal therapeutic agents due to their vast potential in treating various health issues. As significant modulators of the gut microbiota, probiotics are crucial in maintaining intestinal homeostasis and enhancing the synthesis of short-chain fatty acids. Despite extensive research over the past decades, there remains an urgent need for a comprehensive and detailed review that encapsulates probiotics' latest insights and applications. This review focusses on the multifaceted roles of probiotics in promoting health and preventing disease, highlighting the complex mechanisms through which these beneficial bacteria influence both gut flora and the human body at large. This paper also explores probiotics' neurological and gastrointestinal applications, focussing on their significant impact on the gut-brain axis and their therapeutic potential in a broad spectrum of pathological conditions. Current innovations in probiotic formulations, mainly focusing on integrating genomics and biotechnological advancements, have also been comprehensively discussed herein. This paper also critically examines the regulatory landscape that governs probiotic use, ensuring safety and efficacy in clinical and dietary settings. By presenting a comprehensive overview of recent studies and emerging trends, this review aims to illuminate probiotics' extensive therapeutic capabilities, leading to future research and clinical applications. However, besides extensive research, further advanced explorations into probiotic interactions and mechanisms will be essential for developing more targeted and effective therapeutic strategies, potentially revolutionizing health care practices for consumers.

CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges

Abstract Chimeric antigen receptor T (CAR-T) cell therapy, renowned for its successes in cancer treatment, is now entering the field of human immunodeficiency virus (HIV) therapy, presenting both opportunities and challenges. With the emergence of broadly neutralizing antibodies, multi-target CARs, and T cell receptor–like antibodies aimed at increasing specificity in targeting HIV reservoirs, CAR-T therapy is synergizing with other cutting-edge treatments, including gene-editing technologies, therapeutic vaccines, and latency-reversing agents, in pursuit of a potential functional cure. In this review, we delve into the role of CAR-T therapy in HIV treatment, highlighting its potential to overcome clinical obstacles. We discuss advancements in targeting strategies within CAR constructs and the intricate regulation of T cell proliferation and chemotaxis. Moreover, we explore the use of diverse immune cells, such as gamma-delta T cells and natural killer cells. We review advanced biotechnologies, manufacturing innovations, viral mechanisms, and immune microenvironments. We also discuss the current research landscape and potential future applications of CAR-T therapy against HIV, which remains a critical global health challenge.

Advanced Fungal Biotechnologies in Accomplishing Sustainable Development Goals (SDGs): What Do We Know and What Comes Next?

The present era has witnessed an unprecedented scenario with extreme climate changes, depleting natural resources and rising global food demands and its widespread societal impact. From providing bio-based resources to fulfilling socio-economic necessities, tackling environmental challenges, and ecosystem restoration, microbes exist as integral members of the ecosystem and influence human lives. Microbes demonstrate remarkable potential to adapt and thrive in climatic variations and extreme niches and promote environmental sustainability. It is important to mention that advances in fungal biotechnologies have opened new avenues and significantly contributed to improving human lives through addressing socio-economic challenges. Microbe-based sustainable innovations would likely contribute to the United Nations sustainable development goals (SDGs) by providing affordable energy (use of agro-industrial waste by microbial conversions), reducing economic burdens/affordable living conditions (new opportunities by the creation of bio-based industries for a sustainable living), tackling climatic changes (use of sustainable alternative fuels for reducing carbon footprints), conserving marine life (production of microbe-based bioplastics for safer marine life) and poverty reduction (microbial products), among other microbe-mediated approaches. The article highlights the emerging trends and future directions into how fungal biotechnologies can provide feasible and sustainable solutions to achieve SDGs and address global issues.

Revolutionizing Rice: The Synthesis of Nature's Evolution and Biotechnology in C4 Rice

Agriculture plays a fundamental role in meeting the essential needs of humanity, yet numerous factors continuously influence agricultural production and productivity. Over time, evolving agricultural practices have significantly increased yields of staple food crops, thereby enhancing global food security. However, as the world's population continues to grow, there is a pressing need to further augment crop yields. Historically, increases in yield were achieved by expanding cultivated land, but rapid industrialization and urbanization have diminished available agricultural land and depleted natural resources essential for farming. In response to these challenges, enhancing crop photosynthetic efficiency has emerged as a pivotal strategy. Photosynthesis, the process by which plants convert sunlight into energy, has been optimized in various crops through evolutionary and biotechnological approaches. One such innovation is the adaptation of the C4 photosynthetic pathway into C3 rice, a staple food for billions worldwide. The C4 pathway, found in several efficient crops like maize and sugarcane, enhances carbon dioxide uptake and reduces photorespiration, leading to improved water and nitrogen use efficiency. This review explores the integration of nature’s evolutionary principles with cutting-edge biotechnological advancements in the development of C4 rice. By introducing the C4 pathway into rice—a traditionally C3 plant—scientists aim to dramatically increase its productivity and resilience to environmental stressors. This transformative approach not only holds promise for meeting future food demands sustainably but also addresses the challenges posed by climate change and resource scarcity. Moreover, the review examines the scientific basis, technological innovations, and potential agricultural implications of implementing C4 rice. It highlights the collaborative efforts of researchers, agronomists, and biotechnologists worldwide in reimagining rice cultivation to secure global food supplies while minimizing environmental impact. Ultimately, the integration of C4 photosynthesis into rice represents a significant step forward in agricultural innovation, poised to redefine food production capabilities and enhance global food security in the face of escalating population growth and environmental change.

Organization Efficiency Enhancement by DNA Technologies

This research investigates the augmentation of organizational efficiency through the integration of DNA technologies. By leveraging advancements in biotechnology, this study explores novel approaches to enhance processes related to data storage, computation, and information management within organizational frameworks. The utilization of DNA as a storage medium and computational substrate presents opportunities to address scalability challenges and improve overall efficiency. Through case studies and experimental validations, we elucidate the potential impact of DNA technologies on organizational workflows, offering insights into the transformative possibilities for information processing and storage in the evolving landscape of enterprises. Here we evaluate DNA traits by various DNA technologies and create/modify whole space of organizational premises such as office exterior and interior and structures such in such way to accelerate productivity & functioning of overall organisation processes.

Synergistic combination of RAD51-SCR7 improves CRISPR-Cas9 genome editing efficiency by preventing R-loop accumulation

CRISPR-Cas9 has emerged as a powerful tool for genome editing. However, Cas9 genome editing faces challenges, including low efficiency and off-target effects. Here, we report that combined treatment with RAD51, a key factor in homologous recombination, and SCR7, a DNA ligase IV small-molecule inhibitor, enhances CRISPR-Cas9-mediated genome-editing efficiency in human embryonic kidney 293T and human induced pluripotent stem cells, as confirmed by cyro- transmission electron microscopy and functional analyses. First, our findings reveal the crucial role of RAD51 in homologous recombination (HR)-mediated DNA repair process. Elevated levels of exogenous RAD51 promote a post-replication step via single-strandDNA gap repair process, ensuring the completion of DNA replication. Second, using the all-in-one CRISPR-Cas9-RAD51 system, highly expressed RAD51 improved the multiple endogenous gene knockin/knockout efficiency and insertion/deletion (InDel) mutation by activating the HR-based repair pathway in concert with SCR7. Sanger sequencing shows distinct outcomes for RAD51-SCR7 in the ratio of InDel mutations in multiple genome sites. Third, RAD51-SCR7 combination can induce efficient R-loop resolution and DNA repair by enhanced HR process, which leads to DNA replication stalling and thus is advantageous to CRISPR-Cas9-based stable genome editing. Our study suggests promising applications in genome editing by enhancing CRISPR-Cas9 efficiency through RAD51 and SCR7, offering potential advancements in biotechnology and therapeutics.

Microbial Matryoshka: Addressing the Relationship between Pathogenic Flagellated Protozoans and Their RNA Viral Endosymbionts (Family Totiviridae).

Three genera of viruses of the family Totiviridae establish endosymbiotic associations with flagellated protozoa responsible for parasitic diseases of great impact in the context of One Health. Giardiavirus, Trichomonasvirus, and Leishmaniavirus infect the protozoa Giardia sp., Trichomonas vaginalis, and Leishmania sp., respectively. In the present work, we review the characteristics of the endosymbiotic relationships established, the advantages, and the consequences caused in mammalian hosts. Among the common characteristics of these double-stranded RNA viruses are that they do not integrate into the host genome, do not follow a lytic cycle, and do not cause cytopathic effects. However, in cases of endosymbiosis between Leishmaniavirus and Leishmania species from the Americas, and between Trichomonasvirus and Trichomonas vaginalis, it seems that it can alter their virulence (degree of pathogenicity). In a mammalian host, due to TLR3 activation of immune cells upon the recognition of viral RNA, uncontrolled inflammatory signaling responses are triggered, increasing pathological damage and the risk of failure of conventional standard treatment. Endosymbiosis with Giardiavirus can cause the loss of intestinal adherence of the protozoan, resulting in a benign disease. The current knowledge about viruses infecting flagellated protozoans is still fragmentary, and more research is required to unravel the intricacies of this three-way relationship. We need to develop early and effective diagnostic methods for further development in the field of translational medicine. Taking advantage of promising biotechnological advances, the aim is to develop ad hoc therapeutic strategies that focus not only on the disease-causing protozoan but also on the virus.

Molecular farming navigates a complex regulatory landscape.

Molecular farming, the practice of engineering plants to produce recombinant proteins, presents novel challenges and opportunities for domestic markets and international trade. This article explores the multifaceted risks associated with these biotechnological advancements, including public health concerns related to recombinant animal proteins produced in plants, cross-contamination and unintended allergens, and the necessity for stringent identity preservation systems to avoid past failures. On the global stage, the trade of such genetically engineered crops brings about unique regulatory concerns, underscoring the need for internationally harmonized policies and reevaluating existing low-level presence (LLP) thresholds to address unexpected allergens. Moreover, molecular farming ventures into complex religious and ethical territories, particularly affecting communities with strict dietary laws, such as Islamic, Jewish, and those following vegan or vegetarian lifestyles. Addressing these concerns requires a collaborative approach among scientists, regulatory bodies, industry leaders, and religious figures, aiming to foster an inclusive dialogue that navigates the ethical, religious, and environmental implications of integrating animal proteins into plant-based systems. Such efforts are essential for ensuring the responsible development of molecular farming technologies, contributing to a future of sustainable, secure, and inclusive food systems that respect diverse cultural and ethical values.